NEN	niclosamide ethanolamine salt.
mTOR	mammalian target of rapamycin.
IPF	idiopathic pulmonary fibrosis.
EMT	epithelial–mesenchymal transition.
ECM	extracellular matrix.
TGF-β1	transforming growth factor-β.
BLM	bleomycin.
DHLF-IPF	diseased human lung fibroblasts, idiopathic pulmonary fibrosis.
FVC	forced vital capacity.
Cdyn	dynamic compliance.
E-cad	E-cadherin.
VIM	vimentin.
α-SMA	alpha-smooth muscle actin.
FN	fibronectin.
Col-I	type I collagen.